{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:28:27Z","timestamp":1777501707251,"version":"3.51.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.prp.2025.156243","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:55:09Z","timestamp":1758614109000},"page":"156243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Integrative computational and experimental validation of Piperlongumine as a therapeutic agent targeting differentially expressed genes in colorectal cancer"],"prefix":"10.1016","volume":"275","author":[{"given":"Rajeev Kumar","family":"Sahoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahid Alim","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sambit Kumar","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5609-7660","authenticated-orcid":false,"given":"Bijesh Kumar","family":"Biswal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.prp.2025.156243_bib1","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.3390\/cancers16081530","article-title":"Colorectal cancer: epidemiology, risk factors, and prevention","volume":"16","author":"Roshandel","year":"2024","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.prp.2025.156243_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA a cancer journal clinicians"},{"key":"10.1016\/j.prp.2025.156243_bib3","doi-asserted-by":"crossref","first-page":"goac035","DOI":"10.1093\/gastro\/goac035","article-title":"Genetic and epigenetic dependencies in colorectal cancer development","volume":"10","author":"Parmar","year":"2022","journal-title":"Gastroenterol. Rep."},{"issue":"7","key":"10.1016\/j.prp.2025.156243_bib4","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.3390\/jcm12072451","article-title":"Why does obesity as an inflammatory condition predispose to colorectal cancer?","volume":"12","author":"Rychter","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.prp.2025.156243_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.807648","article-title":"Potential role of the gut microbiome in colorectal cancer progression","volume":"12","author":"Kim","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2025.156243_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2023.112334","article-title":"Dietary, addictive and habitual factors, and risk of colorectal cancer","volume":"120","author":"Tufail","year":"2024","journal-title":"Nutrition"},{"issue":"9","key":"10.1016\/j.prp.2025.156243_bib7","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1016\/j.drudis.2022.05.022","article-title":"SOX9 as an emerging target for anticancer drugs and a prognostic biomarker for cancer drug resistance","volume":"27","author":"Tripathi","year":"2022","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.prp.2025.156243_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13046-025-03297-8","article-title":"Extracellular matrix stiffness regulates colorectal cancer progression via HSF4","volume":"44","author":"Wang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.prp.2025.156243_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3892\/ijmm.2021.4847","article-title":"Emerging trends in colorectal cancer: dysregulated signaling pathways","volume":"47","author":"Ahmad","year":"2021","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.prp.2025.156243_bib10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2174\/1874467214666210902115650","article-title":"Impact of sitagliptin on non-diabetic Covid-19 patients","volume":"15","author":"Al-Kuraishy","year":"2022","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.prp.2025.156243_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108179","article-title":"Targeting ligand-dependent wnt pathway dysregulation in gastrointestinal cancers through porcupine inhibition","volume":"238","author":"Flanagan","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"19","key":"10.1016\/j.prp.2025.156243_bib12","doi-asserted-by":"crossref","first-page":"10260","DOI":"10.3390\/ijms221910260","article-title":"Growth factors, PI3K\/AKT\/mTOR and MAPK signaling pathways in colorectal cancer pathogenesis: where are we now?","volume":"22","author":"Stefani","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2025.156243_bib13","doi-asserted-by":"crossref","first-page":"12742","DOI":"10.1038\/s41598-023-39608-2","article-title":"Mutational landscape of cancer-driver genes across human cancers","volume":"13","author":"Sinkala","year":"2023","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.prp.2025.156243_bib14","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.3390\/diagnostics12122985","article-title":"The potential role of MUC16 (CA125) biomarker in lung cancer: a magic biomarker but with adversity","volume":"12","author":"Saad","year":"2022","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.prp.2025.156243_bib15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12964-023-01302-1","article-title":"Unveiling the mechanisms and challenges of cancer drug resistance","volume":"22","author":"Khan","year":"2024","journal-title":"Cell Commun. Signal."},{"issue":"21","key":"10.1016\/j.prp.2025.156243_bib16","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v31.i21.106530","article-title":"Targeting the NAD+\/SIRT1 axis: a metabolic strategy to overcome oxaliplatin resistance in colorectal cancer","volume":"31","author":"Hussain","year":"2025","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.prp.2025.156243_bib17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00210-022-02325-0","article-title":"Commiphora myrrh: a phytochemical and pharmacological update","volume":"396","author":"Batiha","year":"2023","journal-title":"NaunynSchmiede 's. Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.prp.2025.156243_bib18","article-title":"The possible role furin and furin inhibitors in endometrial adenocarcinoma: a narrative review","volume":"7","author":"Al-kuraishy","year":"2024","journal-title":"Cancer Rep."},{"key":"10.1016\/j.prp.2025.156243_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.afres.2025.101132","article-title":"Roles of foods and related components: an overview on cancer causatives, and plausible preventions","author":"Mohammed","year":"2025","journal-title":"Appl. Food Res."},{"issue":"6","key":"10.1016\/j.prp.2025.156243_bib20","doi-asserted-by":"crossref","DOI":"10.4251\/wjgo.v17.i6.105690","article-title":"Progress of traditional Chinese Medicine in the prevention and treatment of colorectal cancer","volume":"17","author":"Mo","year":"2025","journal-title":"World J. Gastrointest. Oncol."},{"issue":"189","key":"10.1016\/j.prp.2025.156243_bib21","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.24976\/Discov.Med.202436189.190","article-title":"Synergistic inhibition of colorectal cancer cells by autocrine motility factor peptide and glycyrrhetinic acid","volume":"36","author":"Kim","year":"2024","journal-title":"Discov. Med."},{"issue":"1","key":"10.1016\/j.prp.2025.156243_bib22","doi-asserted-by":"crossref","first-page":"9677","DOI":"10.1038\/s41598-025-91420-2","article-title":"A fusion model to predict the survival of colorectal cancer based on histopathological image and gene mutation","volume":"15","author":"He","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.156243_bib23","article-title":"Qingjie fuzheng granule prevents colitis-associated colorectal cancer by inhibiting abnormal activation of NOD2\/NF-\u03baB signaling pathway mediated by gut microbiota disorder","author":"Huang","year":"2025","journal-title":"Chin. Herb. Med."},{"key":"10.1016\/j.prp.2025.156243_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104772","article-title":"Piperlongumine, a potent anticancer phytotherapeutic: perspectives on contemporary status and future possibilities as an anticancer agent","volume":"156","author":"Tripathi","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.prp.2025.156243_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10495-022-01711-6","article-title":"Piperlongumine, a piper alkaloid, enhances the efficacy of doxorubicin in breast cancer: involvement of glucose import, ROS, NF-\u03baB and lncRNAs","volume":"27","author":"Awasthee","year":"2022","journal-title":"Apoptosis"},{"key":"10.1016\/j.prp.2025.156243_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-021-03369-0","article-title":"Piperlongumine inhibits migration and proliferation of castration-resistant prostate cancer cells via triggering persistent DNA damage","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Complement. Med. Ther."},{"issue":"8","key":"10.1016\/j.prp.2025.156243_bib27","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1007\/s00210-024-02965-4","article-title":"Exposure of piperlongumine attenuates stemness and epithelial to mesenchymal transition phenotype with more potent anti-metastatic activity in SOX9 deficient human lung cancer cells","volume":"397","author":"Tripathi","year":"2024","journal-title":"NaunynSchmiede 's. Arch. Pharmacol."},{"issue":"17","key":"10.1016\/j.prp.2025.156243_bib28","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.3390\/cancers13174266","article-title":"Piperlongumine, a potent anticancer phytotherapeutic, induces cell cycle arrest and apoptosis in vitro and in vivo through the ROS\/Akt pathway in human thyroid cancer cells","volume":"13","author":"Kung","year":"2021","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.prp.2025.156243_bib29","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.3390\/biomedicines11092442","article-title":"Piperlongumine induces apoptosis and cytoprotective autophagy via the MAPK signaling pathway in human oral cancer cells","volume":"11","author":"Choi","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.prp.2025.156243_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.155945","article-title":"Therapeutic potential of phytocompounds in rheumatoid arthritis: molecular insights and clinical applications","author":"Begh","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2025.156243_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.156144","article-title":"Expression and prognostic analysis of three clones of PD-L1 antibody in colorectal cancer","author":"Gao","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2025.156243_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.155994","article-title":"From blockage to biology: unveiling the role of extracellular matrix dynamics in obstructive colorectal cancer pathogenesis","author":"Wang","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2025.156243_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125721","article-title":"Harnessing MUC1 aptamer-targeted nanoparticles for precision Medicine in breast cancer","author":"Khan","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.prp.2025.156243_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103819","article-title":"Unravelling the potential of mitochondria-targeted liposomes for enhanced cancer treatment","volume":"29","author":"Khan","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.prp.2025.156243_bib35","article-title":"Carbon nanotube-mediated platinum-based drug delivery for the treatment of cancer: advancements and future perspectives","volume":"206","author":"Khan","year":"2024","journal-title":"Eur. Polym. J."},{"issue":"2","key":"10.1016\/j.prp.2025.156243_bib36","doi-asserted-by":"crossref","first-page":"2300370","DOI":"10.1002\/biot.202300370","article-title":"Transforming native exosomes to engineered drug vehicles: a smart solution to modern cancer theranostics","volume":"19","author":"Sahoo","year":"2024","journal-title":"Biotechnol. J."},{"issue":"8","key":"10.1016\/j.prp.2025.156243_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104061","article-title":"Molecular insights to therapeutic in cancer: role of exosomes in tumor microenvironment, metastatic progression and drug resistance","volume":"29","author":"Panda","year":"2024","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.prp.2025.156243_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102177","article-title":"Enigmatic exosomal connection in lung cancer drug resistance","volume":"35","author":"Patra","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.prp.2025.156243_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155761","article-title":"Discovery of LINC01614 associated with the SPP1 gene in colorectal cancer","volume":"266","author":"Norouzinasab","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2025.156243_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155706","article-title":"Advancements in colorectal cancer treatment: the role of metal-based and inorganic nanoparticles in modern therapeutic approaches","volume":"264","author":"Azarian","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2025.156243_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.155909","article-title":"MARCH8 ubiquitinates and degrades CEMIP to induce colorectal cancer cell ferroptosis through inactivating PI3K\/AKT pathway","volume":"269","author":"Liu","year":"2025","journal-title":"Pathol. Res. Pract."},{"issue":"11","key":"10.1016\/j.prp.2025.156243_bib42","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1158\/1078-0432.CCR-11-3066","article-title":"Mutations in the Ras\u2013Raf axis underlie the prognostic value of CD133 in colorectal cancer","volume":"18","author":"Kemper","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.prp.2025.156243_bib43","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1200\/JCO.2006.07.4187","article-title":"Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan","volume":"25","author":"Del Rio","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2025.156243_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.926943","article-title":"A systematic analysis of C5ORF46 in gastrointestinal tumors as a potential prognostic and immunological biomarker","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Genet."},{"issue":"W1","key":"10.1016\/j.prp.2025.156243_bib45","doi-asserted-by":"crossref","first-page":"W191","DOI":"10.1093\/nar\/gkz369","article-title":"G: profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)","volume":"47","author":"Raudvere","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.prp.2025.156243_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294236","article-title":"SRplot: a free online platform for data visualization and graphing","volume":"18","author":"Tang","year":"2023","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.prp.2025.156243_bib47","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.prp.2025.156243_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/jcb.30671","article-title":"Shikonin stimulates Mitochondria-Mediated apoptosis by enhancing intracellular reactive oxygen species production and DNA damage in oral cancer cells","volume":"126","author":"Biswal","year":"2025","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.prp.2025.156243_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119608","article-title":"SOX9 promotes epidermal growth factor receptor-tyrosine kinase inhibitor resistance via targeting \u03b2-catenin and epithelial to mesenchymal transition in lung cancer","volume":"277","author":"Tripathi","year":"2021","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.prp.2025.156243_bib50","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s12276-021-00583-1","article-title":"High prevalence of TP53 loss and whole-genome doubling in early-onset colorectal cancer","volume":"53","author":"Kim","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.prp.2025.156243_bib51","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12943-022-01616-7","article-title":"Wnt signaling in colorectal cancer: pathogenic role and therapeutic target","volume":"21","author":"Zhao","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2025.156243_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15384047.2022.2108690","article-title":"Crosstalk between PI3K\/Akt and Wnt\/\u03b2-catenin pathways promote colorectal cancer progression regardless of mutational status","volume":"23","author":"Fleming-de-Moraes","year":"2022","journal-title":"Cancer Biol. Ther."},{"issue":"5","key":"10.1016\/j.prp.2025.156243_bib53","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41418-022-00962-9","article-title":"Should mutant TP53 be targeted for cancer therapy?","volume":"29","author":"Wang","year":"2022","journal-title":"Cell Death Differ."},{"issue":"10","key":"10.1016\/j.prp.2025.156243_bib54","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/s41419-024-07113-7","article-title":"MAT1A activation of glycolysis to promote NSCLC progression depends on stabilizing CCND1","volume":"15","author":"Shen","year":"2024","journal-title":"Cell Death Dis."},{"issue":"23","key":"10.1016\/j.prp.2025.156243_bib55","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.3390\/cells11233834","article-title":"Delivery of active AKT1 to human cells","volume":"11","author":"Siddika","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.prp.2025.156243_bib56","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00018-023-05099-7","article-title":"Wnt\/\u03b2-catenin-driven EMT regulation in human cancers","volume":"81","author":"Xue","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.prp.2025.156243_bib57","doi-asserted-by":"crossref","first-page":"7352","DOI":"10.1038\/s41598-023-34069-z","article-title":"Common variants of pro-inflammatory gene IL1B and interactions with PPP1R13L and POLR1G in relation to lung cancer among northeast Chinese","volume":"13","author":"Yin","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.156243_bib58","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ygyno.2023.09.009","article-title":"TP53 mutation and abnormal p53 expression in endometrial cancer: associations with race and outcomes","volume":"178","author":"Whelan","year":"2023","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2025.156243_bib59","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1038\/s41598-023-32092-8","article-title":"Different impacts of TP53 mutations on cell cycle-related gene expression among cancer types","volume":"13","author":"Sasaki","year":"2023","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.prp.2025.156243_bib60","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1158\/2159-8290.CD-23-0402","article-title":"Loss-of-function but not gain-of-function properties of mutant TP53 are critical for the proliferation, survival, and metastasis of a broad range of cancer cells","volume":"14","author":"Wang","year":"2024","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.prp.2025.156243_bib61","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1186\/s12885-022-10039-y","article-title":"Clinical significance of p53 protein expression and TP53 variation status in colorectal cancer","volume":"22","author":"Kim","year":"2022","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.prp.2025.156243_bib62","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12943-023-01905-9","article-title":"Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients","volume":"22","author":"Sacconi","year":"2023","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.prp.2025.156243_bib63","article-title":"High-Frequency mutations in TP53, AXIN1, CTNNB1, and KRAS, and polymorphisms in JAK1 genes among Mongolian HCC patients","volume":"8","author":"Bold","year":"2025","journal-title":"Cancer Rep."},{"issue":"1","key":"10.1016\/j.prp.2025.156243_bib64","first-page":"1","article-title":"IL-1\u03b2 and associated molecules as prognostic biomarkers linked with immune cell infiltration in colorectal cancer: an integrated statistical and machine learning approach","volume":"16","author":"Sahoo","year":"2025","journal-title":"Discov. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2025.156243_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijmm.2023.5318","article-title":"Piperlongumine induces apoptosis via the MAPK pathway and ERK\u2011mediated autophagy in human melanoma cells","volume":"52","author":"Jeon","year":"2023","journal-title":"Int. J. Mol. Med."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825004364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825004364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T04:44:38Z","timestamp":1760503478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825004364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":65,"alternative-id":["S0344033825004364"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.156243","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrative computational and experimental validation of Piperlongumine as a therapeutic agent targeting differentially expressed genes in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.156243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156243"}}